![Gary J. G. Atkinson](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Gary J. G. Atkinson
Founder at Zylö Therapeutic, Inc.
Gary J. G. Atkinson active positions
Companies | Position | Start | End |
---|---|---|---|
Zylö Therapeutic, Inc.
![]() Zylö Therapeutic, Inc. BiotechnologyHealth Technology Zylö Therapeutic, Inc. develops a drug-delivery system designed to deliver notoriously hard-to-deliver therapeutic agents. The frim offers patented platform technology that leverages hydrogel-derived nanoparticles to deliver in a sustained and controlled manner therapeutic agents through topical administration, enabling the healthcare industry to harness the therapeutic potential across a variety of applications. The company was founded by Scott R. Pancoast, Joel M. Friedman, Adam Friedman, Lance M. White and Gary J. G. Atkinsonin November 2017 in and is headquartered in Greenville, SC. | Director/Board Member | 2017-10-31 | - |
Founder | 2017-10-31 | - |
Career history of Gary J. G. Atkinson
Former positions of Gary J. G. Atkinson
Companies | Position | Start | End |
---|---|---|---|
Quorex Pharmaceuticals, Inc.
![]() Quorex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Quorex Pharmaceuticals, Inc. was previously engaged in discovering and developing drugs to address the growing need for new therapies to treat bacterial infections. The company's was purchased by Pfizer Inc in 2005. Quorex was headquartered in Carlsbad, CA. | Director of Finance/CFO | 2000-12-31 | 2004-12-31 |
IONIS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 1994-12-31 | 1999-12-31 |
Lpath, Inc.
![]() Lpath, Inc. BiotechnologyHealth Technology Lpath, Inc. operates as a biotechnology company, which focuses on the discovery and development of lipidomic-based therapeutic antibodies, an emerging field of medical science that targets bioactive signaling lipids to treat a wide range of human diseases. It develops three drug candidates, each of them into clinical trials, and built evidence to support their approach of targeting bioactive lipids to treat a wide range of diseases. The company was founded by Roger Allen Sabbadini in September 1997 and is headquartered in San Diego, CA. | Chief Executive Officer | 2015-09-29 | - |
Director of Finance/CFO | 2004-12-31 | - | |
Corporate Secretary | 2004-12-31 | - |
Training of Gary J. G. Atkinson
Brigham Young University | Undergraduate Degree |
Statistics
International
United States | 6 |
Operational
Director of Finance/CFO | 2 |
Chief Executive Officer | 1 |
Corporate Secretary | 1 |
Sectoral
Health Technology | 5 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
IONIS PHARMACEUTICALS, INC. | Health Technology |
Private companies | 3 |
---|---|
Quorex Pharmaceuticals, Inc.
![]() Quorex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Quorex Pharmaceuticals, Inc. was previously engaged in discovering and developing drugs to address the growing need for new therapies to treat bacterial infections. The company's was purchased by Pfizer Inc in 2005. Quorex was headquartered in Carlsbad, CA. | Health Technology |
Lpath, Inc.
![]() Lpath, Inc. BiotechnologyHealth Technology Lpath, Inc. operates as a biotechnology company, which focuses on the discovery and development of lipidomic-based therapeutic antibodies, an emerging field of medical science that targets bioactive signaling lipids to treat a wide range of human diseases. It develops three drug candidates, each of them into clinical trials, and built evidence to support their approach of targeting bioactive lipids to treat a wide range of diseases. The company was founded by Roger Allen Sabbadini in September 1997 and is headquartered in San Diego, CA. | Health Technology |
Zylö Therapeutic, Inc.
![]() Zylö Therapeutic, Inc. BiotechnologyHealth Technology Zylö Therapeutic, Inc. develops a drug-delivery system designed to deliver notoriously hard-to-deliver therapeutic agents. The frim offers patented platform technology that leverages hydrogel-derived nanoparticles to deliver in a sustained and controlled manner therapeutic agents through topical administration, enabling the healthcare industry to harness the therapeutic potential across a variety of applications. The company was founded by Scott R. Pancoast, Joel M. Friedman, Adam Friedman, Lance M. White and Gary J. G. Atkinsonin November 2017 in and is headquartered in Greenville, SC. | Health Technology |
- Stock Market
- Insiders
- Gary J. G. Atkinson
- Experience